Literature DB >> 21982236

Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Aaron R Quinlan1, Michael J Boland, Mitchell L Leibowitz, Svetlana Shumilina, Sidney M Pehrson, Kristin K Baldwin, Ira M Hall.   

Abstract

The biomedical utility of induced pluripotent stem cells (iPSCs) will be diminished if most iPSC lines harbor deleterious genetic mutations. Recent microarray studies have shown that human iPSCs carry elevated levels of DNA copy number variation compared with those in embryonic stem cells, suggesting that these and other classes of genomic structural variation (SV), including inversions, smaller duplications and deletions, complex rearrangements, and retroelement transpositions, may frequently arise as a consequence of reprogramming. Here we employ whole-genome paired-end DNA sequencing and sensitive mapping algorithms to identify all classes of SV in three fully pluripotent mouse iPSC lines. Despite the improved scope and resolution of this study, we find few spontaneous mutations per line (one or two) and no evidence for endogenous retroelement transposition. These results show that genome stability can persist throughout reprogramming, and argue that it is possible to generate iPSCs lacking gene-disrupting mutations using current reprogramming methods.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982236      PMCID: PMC3975295          DOI: 10.1016/j.stem.2011.07.018

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  34 in total

1.  A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome.

Authors:  Oliver A Hampton; Petra Den Hollander; Christopher A Miller; David A Delgado; Jian Li; Cristian Coarfa; Ronald A Harris; Stephen Richards; Steven E Scherer; Donna M Muzny; Richard A Gibbs; Adrian V Lee; Aleksandar Milosavljevic
Journal:  Genome Res       Date:  2008-12-03       Impact factor: 9.043

2.  Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining.

Authors:  Jinshui Fan; Carine Robert; Yoon-Young Jang; Hua Liu; Saul Sharkis; Stephen Bruce Baylin; Feyruz Virgilia Rassool
Journal:  Mutat Res       Date:  2011-06-28       Impact factor: 2.433

3.  Recurrent copy number variations in human induced pluripotent stem cells.

Authors:  Kristen Martins-Taylor; Benjamin S Nisler; Seth M Taapken; Tiwanna Compton; Leann Crandall; Karen Dyer Montgomery; Marc Lalande; Ren-He Xu
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

4.  Reprogramming factor expression initiates widespread targeted chromatin remodeling.

Authors:  Richard P Koche; Zachary D Smith; Mazhar Adli; Hongcang Gu; Manching Ku; Andreas Gnirke; Bradley E Bernstein; Alexander Meissner
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

5.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

6.  Identification and characterization of a novel mouse plexin, plexin-A4.

Authors:  Fumikazu Suto; Yasunori Murakami; Fumio Nakamura; Yoshio Goshima; Hajime Fujisawa
Journal:  Mech Dev       Date:  2003-03       Impact factor: 1.882

Review 7.  Keeping active endogenous retroviral-like elements in check: the epigenetic perspective.

Authors:  I A Maksakova; D L Mager; D Reiss
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

8.  Centrosome/spindle pole-associated protein regulates cytokinesis via promoting the recruitment of MyoGEF to the central spindle.

Authors:  Michael Asiedu; Di Wu; Fumio Matsumura; Qize Wei
Journal:  Mol Biol Cell       Date:  2009-01-07       Impact factor: 4.138

9.  Mapping copy number variation by population-scale genome sequencing.

Authors:  Ryan E Mills; Klaudia Walter; Chip Stewart; Robert E Handsaker; Ken Chen; Can Alkan; Alexej Abyzov; Seungtai Chris Yoon; Kai Ye; R Keira Cheetham; Asif Chinwalla; Donald F Conrad; Yutao Fu; Fabian Grubert; Iman Hajirasouliha; Fereydoun Hormozdiari; Lilia M Iakoucheva; Zamin Iqbal; Shuli Kang; Jeffrey M Kidd; Miriam K Konkel; Joshua Korn; Ekta Khurana; Deniz Kural; Hugo Y K Lam; Jing Leng; Ruiqiang Li; Yingrui Li; Chang-Yun Lin; Ruibang Luo; Xinmeng Jasmine Mu; James Nemesh; Heather E Peckham; Tobias Rausch; Aylwyn Scally; Xinghua Shi; Michael P Stromberg; Adrian M Stütz; Alexander Eckehart Urban; Jerilyn A Walker; Jiantao Wu; Yujun Zhang; Zhengdong D Zhang; Mark A Batzer; Li Ding; Gabor T Marth; Gil McVean; Jonathan Sebat; Michael Snyder; Jun Wang; Kenny Ye; Evan E Eichler; Mark B Gerstein; Matthew E Hurles; Charles Lee; Steven A McCarroll; Jan O Korbel
Journal:  Nature       Date:  2011-02-03       Impact factor: 49.962

10.  Accurate whole human genome sequencing using reversible terminator chemistry.

Authors:  David R Bentley; Shankar Balasubramanian; Harold P Swerdlow; Geoffrey P Smith; John Milton; Clive G Brown; Kevin P Hall; Dirk J Evers; Colin L Barnes; Helen R Bignell; Jonathan M Boutell; Jason Bryant; Richard J Carter; R Keira Cheetham; Anthony J Cox; Darren J Ellis; Michael R Flatbush; Niall A Gormley; Sean J Humphray; Leslie J Irving; Mirian S Karbelashvili; Scott M Kirk; Heng Li; Xiaohai Liu; Klaus S Maisinger; Lisa J Murray; Bojan Obradovic; Tobias Ost; Michael L Parkinson; Mark R Pratt; Isabelle M J Rasolonjatovo; Mark T Reed; Roberto Rigatti; Chiara Rodighiero; Mark T Ross; Andrea Sabot; Subramanian V Sankar; Aylwyn Scally; Gary P Schroth; Mark E Smith; Vincent P Smith; Anastassia Spiridou; Peta E Torrance; Svilen S Tzonev; Eric H Vermaas; Klaudia Walter; Xiaolin Wu; Lu Zhang; Mohammed D Alam; Carole Anastasi; Ify C Aniebo; David M D Bailey; Iain R Bancarz; Saibal Banerjee; Selena G Barbour; Primo A Baybayan; Vincent A Benoit; Kevin F Benson; Claire Bevis; Phillip J Black; Asha Boodhun; Joe S Brennan; John A Bridgham; Rob C Brown; Andrew A Brown; Dale H Buermann; Abass A Bundu; James C Burrows; Nigel P Carter; Nestor Castillo; Maria Chiara E Catenazzi; Simon Chang; R Neil Cooley; Natasha R Crake; Olubunmi O Dada; Konstantinos D Diakoumakos; Belen Dominguez-Fernandez; David J Earnshaw; Ugonna C Egbujor; David W Elmore; Sergey S Etchin; Mark R Ewan; Milan Fedurco; Louise J Fraser; Karin V Fuentes Fajardo; W Scott Furey; David George; Kimberley J Gietzen; Colin P Goddard; George S Golda; Philip A Granieri; David E Green; David L Gustafson; Nancy F Hansen; Kevin Harnish; Christian D Haudenschild; Narinder I Heyer; Matthew M Hims; Johnny T Ho; Adrian M Horgan; Katya Hoschler; Steve Hurwitz; Denis V Ivanov; Maria Q Johnson; Terena James; T A Huw Jones; Gyoung-Dong Kang; Tzvetana H Kerelska; Alan D Kersey; Irina Khrebtukova; Alex P Kindwall; Zoya Kingsbury; Paula I Kokko-Gonzales; Anil Kumar; Marc A Laurent; Cynthia T Lawley; Sarah E Lee; Xavier Lee; Arnold K Liao; Jennifer A Loch; Mitch Lok; Shujun Luo; Radhika M Mammen; John W Martin; Patrick G McCauley; Paul McNitt; Parul Mehta; Keith W Moon; Joe W Mullens; Taksina Newington; Zemin Ning; Bee Ling Ng; Sonia M Novo; Michael J O'Neill; Mark A Osborne; Andrew Osnowski; Omead Ostadan; Lambros L Paraschos; Lea Pickering; Andrew C Pike; Alger C Pike; D Chris Pinkard; Daniel P Pliskin; Joe Podhasky; Victor J Quijano; Come Raczy; Vicki H Rae; Stephen R Rawlings; Ana Chiva Rodriguez; Phyllida M Roe; John Rogers; Maria C Rogert Bacigalupo; Nikolai Romanov; Anthony Romieu; Rithy K Roth; Natalie J Rourke; Silke T Ruediger; Eli Rusman; Raquel M Sanches-Kuiper; Martin R Schenker; Josefina M Seoane; Richard J Shaw; Mitch K Shiver; Steven W Short; Ning L Sizto; Johannes P Sluis; Melanie A Smith; Jean Ernest Sohna Sohna; Eric J Spence; Kim Stevens; Neil Sutton; Lukasz Szajkowski; Carolyn L Tregidgo; Gerardo Turcatti; Stephanie Vandevondele; Yuli Verhovsky; Selene M Virk; Suzanne Wakelin; Gregory C Walcott; Jingwen Wang; Graham J Worsley; Juying Yan; Ling Yau; Mike Zuerlein; Jane Rogers; James C Mullikin; Matthew E Hurles; Nick J McCooke; John S West; Frank L Oaks; Peter L Lundberg; David Klenerman; Richard Durbin; Anthony J Smith
Journal:  Nature       Date:  2008-11-06       Impact factor: 49.962

View more
  54 in total

1.  The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.

Authors:  Junjie Lu; Hu Li; Ming Hu; Takayo Sasaki; Anna Baccei; David M Gilbert; Jun S Liu; James J Collins; Paul H Lerou
Journal:  Cell Rep       Date:  2014-03-27       Impact factor: 9.423

Review 2.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 3.  The Retrotransposon storm and the dangers of a Collyer's genome.

Authors:  Josh Dubnau
Journal:  Curr Opin Genet Dev       Date:  2018-05-08       Impact factor: 5.578

Review 4.  Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.

Authors:  Kai-C Sonntag; Bin Song; Nayeon Lee; Jin Hyuk Jung; Young Cha; Pierre Leblanc; Carolyn Neff; Sek Won Kong; Bob S Carter; Jeffrey Schweitzer; Kwang-Soo Kim
Journal:  Prog Neurobiol       Date:  2018-04-11       Impact factor: 11.685

5.  Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis.

Authors:  Julia Deinsberger; David Reisinger; Benedikt Weber
Journal:  NPJ Regen Med       Date:  2020-09-11

6.  iPSCs and fibroblast subclones from the same fibroblast population contain comparable levels of sequence variations.

Authors:  Erika M Kwon; John P Connelly; Nancy F Hansen; Frank X Donovan; Thomas Winkler; Brian W Davis; Halah Alkadi; Settara C Chandrasekharappa; Cynthia E Dunbar; James C Mullikin; Paul Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-06       Impact factor: 11.205

Review 7.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

8.  Influence of donor age on induced pluripotent stem cells.

Authors:  Valentina Lo Sardo; William Ferguson; Galina A Erikson; Eric J Topol; Kristin K Baldwin; Ali Torkamani
Journal:  Nat Biotechnol       Date:  2016-12-12       Impact factor: 54.908

Review 9.  Does transcription factor induced pluripotency accurately mimic embryo derived pluripotency?

Authors:  William E Lowry
Journal:  Curr Opin Genet Dev       Date:  2012-10-15       Impact factor: 5.578

10.  Passage number is a major contributor to genomic structural variations in mouse iPSCs.

Authors:  Pengfei Liu; Anna Kaplan; Bo Yuan; Jacob H Hanna; James R Lupski; Orly Reiner
Journal:  Stem Cells       Date:  2014-10       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.